ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,623,000 | -3.7% | 44,045 | +10.3% | 0.01% | -15.4% |
Q2 2021 | $2,723,000 | +92.2% | 39,923 | +95.5% | 0.01% | +85.7% |
Q1 2021 | $1,417,000 | +28.4% | 20,418 | +42.1% | 0.01% | +40.0% |
Q4 2020 | $1,104,000 | +10.1% | 14,365 | +7.2% | 0.01% | -16.7% |
Q3 2020 | $1,003,000 | +32.1% | 13,406 | +11.2% | 0.01% | +50.0% |
Q2 2020 | $759,000 | – | 12,053 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |